News

An academic article on the results of the clinical trial, “ONE BRIDGE” study developing a treatment for patients with pneumonia induced ARDS using HLCM051, has been published in the peer-reviewed journal “Stem Cell Research & Therapy”.

Title: Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: A randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)